Analysis of PsA guidelines reveals much room for improvement on conflicts of interestOctober 6, 2022Psoriatic Arthritis
Sex differences seen in inflammatory arthritis health care useSeptember 30, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
Psoriasis, psoriatic arthritis insurance coverage remains restrictiveSeptember 26, 2022Psoriatic Arthritis
Apremilast alleviates severe psoriasis in some children, data showSeptember 20, 2022Psoriatic ArthritisPediatrics
Brodalumab suicide risk similar to other biologics, postmarket study findsSeptember 19, 2022Psoriatic ArthritisMixed Topics
Autoimmune diseases linked to spike in post-MI eventsSeptember 15, 2022Lupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid Arthritis
Sustained response at 2 years reported for newly approved oral psoriasis agentSeptember 15, 2022Psoriatic Arthritis
FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasisSeptember 12, 2022Psoriatic Arthritis
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?September 8, 2022Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Inhaled, systemic steroids linked to changes in brain structureAugust 31, 2022ImagingMixed TopicsRheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic Arthritis
OMERACT continues to set standards on research outcomes, enhancing the patient voiceAugust 30, 2022Rheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic ArthritisSpondyloarthropathiesGoutAnkylosing spondylitisOsteoarthritis
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Asian patients with psoriasis have shortest visits, study showsAugust 24, 2022Psoriatic ArthritisDiversity in Medicine
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration formAugust 17, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review revealsAugust 15, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsLupus & Connective Tissue DiseasesAnkylosing spondylitis
